What happened
Hone Health, a direct-to-consumer longevity company, has secured $228 million in new financing, MedCity News reported. The package combines $28 million of Series A equity with $200 million of growth capital supplied by the Customer Value Fund at General Catalyst. MarcyPen Capital Partners led the financing. Other backers included Hanwha, ID Ventures, Kinship Ventures, Comma Capital, Pentland Ventures, humbition and Gannet Capital.
The company sells access to biomarker testing, doctor consultations and tailored treatments for areas including menopause, weight management, thyroid, heart and sexual health, and says it has served over 200,000 patients. The new money will go toward programs in metabolic health, inflammation and immunity, adding diagnostics such as MRIs and gut microbiome tests, upgrading its AI tools for clinicians, a peptide program and clinical trials infrastructure.
Alongside the raise, Hone Health introduced Hone Black, a concierge membership that had been kept in stealth for about a year. It bundles testing of more than 1,600 biomarkers, hormonal, metabolic and cognitive health care, advanced treatments and support from a dedicated concierge team. Co-founder and CEO Saad Alam said the longer-term aim is a research platform that improves outcomes and helps people live longer.
Context
Hone Health positions itself around a gap Alam described: people can see more data about their bodies than ever but get little direction on how to act on it. Kinship Ventures co-founder Gwyneth Paltrow, who also founded the wellness company Goop, said wellness has grown from a niche topic into one of the largest categories globally, and that Kinship backed Hone for its scientific approach and scale.
简报
一封邮件,尽览一周科技要闻。
每周精选值得一读的报道。可随时退订。
